chr11-5788800-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001913.2(OR52N1):c.17G>A(p.Gly6Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,602,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001913.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR52N1 | NM_001001913.2 | c.17G>A | p.Gly6Asp | missense_variant | 2/2 | ENST00000641645.1 | NP_001001913.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR52N1 | ENST00000641645.1 | c.17G>A | p.Gly6Asp | missense_variant | 2/2 | NM_001001913.2 | ENSP00000493272 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-61-108562G>A | intron_variant | 1 | ENSP00000388031 | |||||
TRIM5 | ENST00000380027.5 | c.-441+66952G>A | intron_variant | 5 | ENSP00000369366 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151972Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000374 AC: 9AN: 240568Hom.: 0 AF XY: 0.0000230 AC XY: 3AN XY: 130654
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1450938Hom.: 0 Cov.: 37 AF XY: 0.00000693 AC XY: 5AN XY: 721908
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151972Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74194
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.17G>A (p.G6D) alteration is located in exon 1 (coding exon 1) of the OR52N1 gene. This alteration results from a G to A substitution at nucleotide position 17, causing the glycine (G) at amino acid position 6 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at